RHO and retinal disorder: This review also integrates and updates the information on pharmacological intervention, optogenetics, gene therapy and gene editing, and stem cell therapy for rhodopsin-related retinal disorders that were reviewed previously (Athanasiou et al., 2018; Ikelle et al., 2020; Meng et al., 2020; Ortega and Jastrzebska, 2021; Piri et al., 2021; Ortega and Jastrzebska, 2022).